# ADC Therapeutics SA > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:886b19eb-fab1-4a15-829d-8b90daff05df | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/adc-therapeutics-sa | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 30 | | Claims under review | 1 | | Evidence records | 3 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-17T04:46:43.578776+00:00 | | Last reviewed | 2026-10-17T04:46:43.578776+00:00 | ## Identity - Legal name: ADC Therapeutics SA - Display name: ADC Therapeutics SA ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T09:21:31.389773+00:00 | | Completeness | 0.364 | | Record Quality | 0.827 | | Directors | 12 | | Committees | 8 | | Governance events | 19 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | NOT_REVIEWED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Ameet Mallik: Director. Status: current. Independent: false. Since: 2022-01-01. claim_id=alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:7 - Jean-Pierre Bizzari: Director. Status: current. Independent: true. Since: 2022-01-01. Committees: Nominating and Governance (chair); Nominating and Governance · Chair (member). claim_id=alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:8 - Peter Hug: Director. Status: current. Independent: true. Since: 2019-01-01. Committees: Compensation (chair); Compensation · Chair; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:11 - Robert Azelby: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Audit (member); Audit; Compensation (member); Compensation (member). claim_id=alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:13 - Ron Squarer: Director. Status: current. Independent: false. Since: 2020-01-01. claim_id=alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:14 - Timothy Coughlin: Director. Status: current. Independent: true. Since: 2025-01-01. Committees: Audit (chair); Audit · Chair (member). claim_id=alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:15 - Tyrell J. Rivers: Director. Status: current. Independent: true. Since: 2018-01-01. claim_id=alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:16 - Victor Sandor: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:17 - Viviane Monges: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Audit (member); Audit; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:18 - Jose Pepe Carmona: Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:9 - Mohamed Zaki: Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:10 - Peter J. Graham: Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:12 ## Committees - Audit (audit). Chair: Timothy Coughlin. Members: Timothy Coughlin (chair, current); Robert Azelby (member, current); Viviane Monges (member, current). committee_id=alpha:committee:adc-therapeutics-sa:audit - Audit · Chair (audit). Chair: NOT_PUBLISHED. Members: Timothy Coughlin (member, current). committee_id=alpha:committee:adc-therapeutics-sa:audit-chair - Audit; Compensation (audit). Chair: NOT_PUBLISHED. Members: Robert Azelby (member, current). committee_id=alpha:committee:adc-therapeutics-sa:audit-compensation - Audit; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Viviane Monges (member, current). committee_id=alpha:committee:adc-therapeutics-sa:audit-nominating-and-governance - Compensation (compensation). Chair: Peter Hug. Members: Peter Hug (chair, current); Robert Azelby (member, current); Victor Sandor (member, current). committee_id=alpha:committee:adc-therapeutics-sa:compensation - Compensation · Chair; Nominating and Governance (compensation). Chair: NOT_PUBLISHED. Members: Peter Hug (member, current). committee_id=alpha:committee:adc-therapeutics-sa:compensation-chair-nominating-and-governance - Nominating and Governance (nominating_governance). Chair: Jean-Pierre Bizzari. Members: Jean-Pierre Bizzari (chair, current); Peter Hug (member, current); Viviane Monges (member, current). committee_id=alpha:committee:adc-therapeutics-sa:nominating-and-governance - Nominating and Governance · Chair (nominating_governance). Chair: NOT_PUBLISHED. Members: Jean-Pierre Bizzari (member, current). committee_id=alpha:committee:adc-therapeutics-sa:nominating-and-governance-chair ## Governance events - DIRECTOR_APPOINTED: Timothy Coughlin seat on ADC Therapeutics SA, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:1igw1entwkrhh - COMMITTEE_CREATED: Audit · Chair committee of ADC Therapeutics SA, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:n6axrj11wt8hp - COMMITTEE_MEMBER_ADDED: Timothy Coughlin member of Audit · Chair, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:s34i2n30yhtn - DIRECTOR_APPOINTED: Robert Azelby seat on ADC Therapeutics SA, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:c5y4jp1a39uvt - COMMITTEE_CREATED: Audit; Compensation committee of ADC Therapeutics SA, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:5ja545edkv95 - COMMITTEE_MEMBER_ADDED: Robert Azelby member of Audit; Compensation, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:z4u4xm16texwe - DIRECTOR_APPOINTED: Ameet Mallik seat on ADC Therapeutics SA, effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:sx1vxn1mltseh - DIRECTOR_APPOINTED: Jean-Pierre Bizzari seat on ADC Therapeutics SA, effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:1xlozu61d90436 - COMMITTEE_CREATED: Nominating and Governance · Chair committee of ADC Therapeutics SA, effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:8jjde1jti3g2 - COMMITTEE_MEMBER_ADDED: Jean-Pierre Bizzari member of Nominating and Governance · Chair, effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:1k3ceywrmb6pe - DIRECTOR_APPOINTED: Viviane Monges seat on ADC Therapeutics SA, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:20yzxgvbm5qw - COMMITTEE_CREATED: Audit; Nominating and Governance committee of ADC Therapeutics SA, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:2xr9u2lz8u90 - COMMITTEE_MEMBER_ADDED: Viviane Monges member of Audit; Nominating and Governance, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:19dk430qb7ouw - DIRECTOR_APPOINTED: Ron Squarer seat on ADC Therapeutics SA, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:rtmxrnpo4ydl - DIRECTOR_APPOINTED: Victor Sandor seat on ADC Therapeutics SA, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:2mz3e21qwnh2 - DIRECTOR_APPOINTED: Peter Hug seat on ADC Therapeutics SA, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:1ljkmjk1gle01y - COMMITTEE_CREATED: Compensation · Chair; Nominating and Governance committee of ADC Therapeutics SA, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:a3rar214sbmpe - COMMITTEE_MEMBER_ADDED: Peter Hug member of Compensation · Chair; Nominating and Governance, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:3rv73n1nrq1k7 - DIRECTOR_APPOINTED: Tyrell J. Rivers seat on ADC Therapeutics SA, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-17T04:46:43.578776+00:00. event_id=alpha:event:transition:12h8fn2hcx13c ## Scoped resources - `alpha://company/adc-therapeutics-sa` (contract): https://registry.alpha.ac/api/public/companies/adc-therapeutics-sa?format=record - `alpha://company/adc-therapeutics-sa/identity` (contract): https://registry.alpha.ac/api/public/companies/adc-therapeutics-sa?format=record§ion=identity - `alpha://company/adc-therapeutics-sa/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/adc-therapeutics-sa?format=record§ion=corporate-structure - `alpha://company/adc-therapeutics-sa/board` (contract): https://registry.alpha.ac/api/public/companies/adc-therapeutics-sa?format=record§ion=board - `alpha://company/adc-therapeutics-sa/committees` (contract): https://registry.alpha.ac/api/public/companies/adc-therapeutics-sa?format=record§ion=committees - `alpha://company/adc-therapeutics-sa/leadership` (contract): https://registry.alpha.ac/api/public/companies/adc-therapeutics-sa?format=record§ion=leadership - `alpha://company/adc-therapeutics-sa/ownership` (contract): https://registry.alpha.ac/api/public/companies/adc-therapeutics-sa?format=record§ion=ownership - `alpha://company/adc-therapeutics-sa/financials` (contract): https://registry.alpha.ac/api/public/companies/adc-therapeutics-sa?format=record§ion=financials - `alpha://company/adc-therapeutics-sa/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/adc-therapeutics-sa?format=record§ion=capital-structure - `alpha://company/adc-therapeutics-sa/compensation` (contract): https://registry.alpha.ac/api/public/companies/adc-therapeutics-sa?format=record§ion=compensation - `alpha://company/adc-therapeutics-sa/governance` (contract): https://registry.alpha.ac/api/public/companies/adc-therapeutics-sa?format=record§ion=governance - `alpha://company/adc-therapeutics-sa/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/adc-therapeutics-sa?format=record§ion=shareholder-governance - `alpha://company/adc-therapeutics-sa/audit` (contract): https://registry.alpha.ac/api/public/companies/adc-therapeutics-sa?format=record§ion=audit - `alpha://company/adc-therapeutics-sa/legal` (contract): https://registry.alpha.ac/api/public/companies/adc-therapeutics-sa?format=record§ion=legal - `alpha://company/adc-therapeutics-sa/risk` (contract): https://registry.alpha.ac/api/public/companies/adc-therapeutics-sa?format=record§ion=risk - `alpha://company/adc-therapeutics-sa/cyber` (contract): https://registry.alpha.ac/api/public/companies/adc-therapeutics-sa?format=record§ion=cyber - `alpha://company/adc-therapeutics-sa/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/adc-therapeutics-sa?format=record§ion=ai-governance - `alpha://company/adc-therapeutics-sa/agents` (contract): https://registry.alpha.ac/api/public/companies/adc-therapeutics-sa?format=record§ion=agents - `alpha://company/adc-therapeutics-sa/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/adc-therapeutics-sa?format=record§ion=ecosystem - `alpha://company/adc-therapeutics-sa/events` (contract): https://registry.alpha.ac/api/public/companies/adc-therapeutics-sa?format=record§ion=events - `alpha://company/adc-therapeutics-sa/relationships` (contract): https://registry.alpha.ac/api/public/companies/adc-therapeutics-sa?format=record§ion=relationships - `alpha://company/adc-therapeutics-sa/assessments` (contract): https://registry.alpha.ac/api/public/companies/adc-therapeutics-sa?format=record§ion=assessments - `alpha://company/adc-therapeutics-sa/evidence` (contract): https://registry.alpha.ac/api/public/companies/adc-therapeutics-sa?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:timothy-coughlin","name":"Timothy Coughlin"},"source_id":"board_seats"}` - Claim alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:robert-azelby","name":"Robert Azelby"},"source_id":"board_seats"}` - Claim alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:viviane-monges","name":"Viviane Monges"},"source_id":"board_seats"}` - Claim alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:peter-hug","name":"Peter Hug"},"source_id":"board_seats"}` - Claim alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_appointment:25: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:robert-azelby","name":"Robert Azelby"},"source_id":"board_seats"}` - Claim alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:victor-sandor","name":"Victor Sandor"},"source_id":"board_seats"}` - Claim alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_appointment:28: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:jean-pierre-bizzari","name":"Jean-Pierre Bizzari"},"source_id":"board_seats"}` - Claim alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_appointment:29: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:peter-hug","name":"Peter Hug"},"source_id":"board_seats"}` - Claim alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_appointment:30: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:viviane-monges","name":"Viviane Monges"},"source_id":"board_seats"}` ## Leadership - Ameet Mallik: Director. Claim: alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:7. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d. - Jean-Pierre Bizzari: Director, Nominating and Governance · Chair. Claim: alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:8. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d. - Jose Pepe Carmona: Director. Claim: alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d. - Mohamed Zaki: Director. Claim: alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d. - Peter Hug: Director, Compensation · Chair; Nominating and Governance. Claim: alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:11. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d. - Peter J. Graham: Director. Claim: alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d. - Robert Azelby: Director, Audit; Compensation. Claim: alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:13. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d. - Ron Squarer: Director. Claim: alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:14. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d. - Timothy Coughlin: Director, Audit · Chair. Claim: alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:15. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d. - Tyrell J. Rivers: Director. Claim: alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:16. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d. - Victor Sandor: Director, Compensation. Claim: alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:17. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d. - Viviane Monges: Director, Audit; Nominating and Governance. Claim: alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:leadership_role:18. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Timothy Coughlin; Members Timothy Coughlin (Chair); Robert Azelby; Viviane Monges. Claim: alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_record:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f65edb94619d7264a647b740d07118cda1761c6182e072feeac4fae01d9de922. - Compensation: Chair Peter Hug; Members Peter Hug (Chair); Robert Azelby; Victor Sandor. Claim: alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_record:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f65edb94619d7264a647b740d07118cda1761c6182e072feeac4fae01d9de922. - Nominating and Governance: Chair Jean-Pierre Bizzari; Members Jean-Pierre Bizzari (Chair); Peter Hug; Viviane Monges. Claim: alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_record:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f65edb94619d7264a647b740d07118cda1761c6182e072feeac4fae01d9de922. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - ADC Therapeutics SA. Claim: alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:05009e4fda865438b5485f19251b192af49ba3921abcd6f08c7faa0e3bd53cc4. ## Entity Status - Public listing published. Claim: alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:05009e4fda865438b5485f19251b192af49ba3921abcd6f08c7faa0e3bd53cc4. ## Published Fact - US. Claim: alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:05009e4fda865438b5485f19251b192af49ba3921abcd6f08c7faa0e3bd53cc4. - Healthcare. Claim: alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:05009e4fda865438b5485f19251b192af49ba3921abcd6f08c7faa0e3bd53cc4. - Biotechnology. Claim: alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:published_fact:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:05009e4fda865438b5485f19251b192af49ba3921abcd6f08c7faa0e3bd53cc4. ## Committee Appointment - Timothy Coughlin: chair, Audit. Claim: alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f65edb94619d7264a647b740d07118cda1761c6182e072feeac4fae01d9de922. - Robert Azelby: member, Audit. Claim: alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f65edb94619d7264a647b740d07118cda1761c6182e072feeac4fae01d9de922. - Viviane Monges: member, Audit. Claim: alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f65edb94619d7264a647b740d07118cda1761c6182e072feeac4fae01d9de922. - Peter Hug: chair, Compensation. Claim: alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f65edb94619d7264a647b740d07118cda1761c6182e072feeac4fae01d9de922. - Robert Azelby: member, Compensation. Claim: alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_appointment:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f65edb94619d7264a647b740d07118cda1761c6182e072feeac4fae01d9de922. - Victor Sandor: member, Compensation. Claim: alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f65edb94619d7264a647b740d07118cda1761c6182e072feeac4fae01d9de922. - Jean-Pierre Bizzari: chair, Nominating and Governance. Claim: alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_appointment:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f65edb94619d7264a647b740d07118cda1761c6182e072feeac4fae01d9de922. - Peter Hug: member, Nominating and Governance. Claim: alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_appointment:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f65edb94619d7264a647b740d07118cda1761c6182e072feeac4fae01d9de922. - Viviane Monges: member, Nominating and Governance. Claim: alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:committee_appointment:30. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f65edb94619d7264a647b740d07118cda1761c6182e072feeac4fae01d9de922. ## Security Listing - ADCT (NYSE). Claim: alpha:claim:company:886b19eb-fab1-4a15-829d-8b90daff05df:security_listing:31. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:05009e4fda865438b5485f19251b192af49ba3921abcd6f08c7faa0e3bd53cc4. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:05009e4fda865438b5485f19251b192af49ba3921abcd6f08c7faa0e3bd53cc4: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/adc-therapeutics-sa). - alpha:projection-evidence:document:5e4bd5cebc545453d9cc5648ed206c26f8bb9a8bf4d56c0233088226c4c1f16d: [ADC Therapeutics SA DEF 14A 2026-04-20](https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm). - alpha:projection-evidence:f65edb94619d7264a647b740d07118cda1761c6182e072feeac4fae01d9de922: [Audit](https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/adc-therapeutics-sa) - [Public Markdown](https://registry.alpha.ac/companies/adc-therapeutics-sa.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/adc-therapeutics-sa?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/adc-therapeutics-sa?format=jsonld) - MCP resource: `alpha://companies/adc-therapeutics-sa` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T09:21:31.170125+00:00; recorded 2026-10-17T09:21:31.170125+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.